Ph3 Study of Exemestane With or Without Entinostat in Chinese Patients With Hormone Receptor-Positive, Locally Advanced or Metastatic Breast Cancer
Clinical trial NCT03538171 · UNKNOWN
Trial details
- NCT number
- NCT03538171
- Sponsor
- Taizhou EOC Pharma Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-15
- Primary completion
- 2021-07-01
- Enrollment
- 375
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.